GlassScriptPhysician profile
Buba Marong
NPI 1124523147
$3,721.53
in general payments reported to CMS, 2019-2025
25 companies · $1,843 in 2025
The $1,843 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $427 · 2024: $1,451 · 2025: $1,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,451 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,451.32 |
| Education | $270.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $662.55 | 2024-2025 | Ensite, Dragonfly Opstar, Aptivue |
| Novartis Pharmaceuticals Corporation | $422.74 | 2023-2025 | |
| Medtronic, INC. | $372.69 | 2023-2025 | Onyx Frontier, Symplicity G3, Azure Xt Dr Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $303.76 | 2024-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $302.63 | 2023-2025 | Assure Wcd |
| Boston Scientific Corporation | $291.45 | 2023-2024 | Avvigo Guidance System, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Shockwave Medical, INC | $198.61 | 2025 | |
| Abiomed | $183.01 | 2025 | |
| Cardiac Dimensions, INC. | $148.19 | 2024 | |
| Bridgebio Pharma, INC. | $128.47 | 2025 | Attruby |
| Cook Medical LLC | $107.85 | 2024 | Micropuncture |
| Lantheus Medical Imaging, INC. | $98.33 | 2023-2024 | Definity |
| Kiniksa Pharmaceuticals International, Plc | $98.02 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $68.98 | 2025 | Evkeeza |
| Irhythm Technologies, INC. | $63.76 | 2023-2024 | Zio Xt Patch, Zio Monitor |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $57.54 | 2023-2024 | (Ck4) Mcot |
| Cvrx, INC. | $41.70 | 2024-2025 | Barostim Neo System |
| Amgen INC. | $36.68 | 2025 | Repatha |
| Novo Nordisk INC | $24.30 | 2024 | Rybelsus, Ozempic |
| Kiniksa Pharmaceuticals, LTD. | $23.64 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $19.08 | 2025 | |
| Baxter Healthcare | $17.89 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Janssen Pharmaceuticals, INC | $17.05 | 2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $16.99 | 2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $15.62 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Buba Marong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.